HAP Trading’s ChemoCentryx, Inc. CCXI Stock Holding History

HAP Trading’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-33,500	Closed	-$467K	–	2010
2022 Q3	$467K	Buy	33,500 +3,100	+10%	+$128K	0.03%	377
2022 Q2	$90K	Buy	30,400 +19,000	+167%	+$419K	﹤0.01%	912
2022 Q1	$33K	Sell	11,400 -2,500	-18%	-$70.3K	﹤0.01%	1382
2021 Q4	$98K	Sell	13,900 -10,500	-43%	-$369K	﹤0.01%	1245
2021 Q3	$134K	Sell	24,400 -25,400	-51%	-$396K	﹤0.01%	1170
2021 Q2	$157K	Buy	+49,800	New	+$1.23M	﹤0.01%	1086
2020 Q3	–	Sell	-450,300	Closed	-$4.64M	–	2016
2020 Q2	$4.64M	Buy	+450,300	New	+$24.5M	0.25%	72

Other funds holding CCXI

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

HAP Trading's CCXI Position: Q2 2022 in Review

HAP Trading sold out of ChemoCentryx, Inc. (CCXI) in Q2 2022, closing a stake of 18,536 shares — an estimated $409K sold.

HAP Trading first reported a position in CCXI in Q2 2021 and held it in 4 quarters. The position peaked at $883K in Q4 2021. 182 funds tracked by Wall St. Rank hold CCXI as of Q2 2022.

HAP Trading reported no remaining ChemoCentryx, Inc. position as of Q2 2022 after selling out during the quarter.
HAP Trading sold 18,536 ChemoCentryx, Inc. shares in Q2 2022, an estimated $409K.
HAP Trading first reported a position in ChemoCentryx, Inc. in Q2 2021 and held it in 4 quarters.
HAP Trading's ChemoCentryx, Inc. position peaked at $883K in Q4 2021.
182 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q2 2022.

Based on HAP Trading's 13F filing for Q2 2022, filed 12 Aug 2022.